Movement Disorder News and Research

Latest Movement Disorder News and Research

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Rexahn Pharmaceuticals submits Phase II protocol for study of Serdaxin in treatment of PD

Rexahn Pharmaceuticals submits Phase II protocol for study of Serdaxin in treatment of PD

Top neurologists to receive 2010 AAN Alliance Awards

Top neurologists to receive 2010 AAN Alliance Awards

New devices pave way for applications in cardiology and neurology

New devices pave way for applications in cardiology and neurology

St. Jude Medical's Brio DBS system for treating Parkinson’s disease receives Australian TGA approval

St. Jude Medical's Brio DBS system for treating Parkinson’s disease receives Australian TGA approval

Rexahn Pharmaceuticals forms Parkinson’s Disease SAB to develop strategy for Serdaxin

Rexahn Pharmaceuticals forms Parkinson’s Disease SAB to develop strategy for Serdaxin

Manhattan Pharmaceuticals to merge with Ariston Pharmaceuticals

Manhattan Pharmaceuticals to merge with Ariston Pharmaceuticals

Ampicillin activates torsinA, improves cell function to reduce movement disorders

Ampicillin activates torsinA, improves cell function to reduce movement disorders

DSPA's lurasidone NDA accepted for FDA review

DSPA's lurasidone NDA accepted for FDA review

Omeros obtains exclusive license to compounds from Asubio Pharma for use in its PDE7 program

Omeros obtains exclusive license to compounds from Asubio Pharma for use in its PDE7 program

NAF to hold third annual Ataxia Investigators Meeting in Rosemont

NAF to hold third annual Ataxia Investigators Meeting in Rosemont

Parkinson's patients find facial and vocal expression difficult to read; deep brain stimulation seems to make it worse

Parkinson's patients find facial and vocal expression difficult to read; deep brain stimulation seems to make it worse

Allergan celebrates 20th anniversary of BOTOX in Canada

Allergan celebrates 20th anniversary of BOTOX in Canada

Focal dystonia precipitated by odor exposure: First case reported

Focal dystonia precipitated by odor exposure: First case reported

Researchers proceed to develop vaccination to reverse neurological damage seen with Parkinson's disease

Researchers proceed to develop vaccination to reverse neurological damage seen with Parkinson's disease

WSU Boonshoft School of Medicine and Miami Valley Hospital form new neuroscience institute

WSU Boonshoft School of Medicine and Miami Valley Hospital form new neuroscience institute

Medtronic third-quarter revenues up by 10%

Medtronic third-quarter revenues up by 10%

Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD

Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD

New foundational research may advance pharmacological therapies for neurological disorders

New foundational research may advance pharmacological therapies for neurological disorders